Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Embrace TDD: Post-Market Study to Evaluate Intrathecal Morphine as an Alternative to Systemic Opioids for Chronic Pain

ClinicalTrials.gov ID: NCT03761277

Public ClinicalTrials.gov record NCT03761277. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 1:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Embrace TDD: Prospective, Multi-Center, Post Market Study to Evaluate Intrathecal (IT) Morphine as an Alternative to Systemic Opioids for the Treatment of Chronic, Intractable, Non-Malignant Primary Back Pain With or Without Leg Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a prospective, multi-center, post market study to evaluate Intrathecal (IT) preservative-free morphine sulfate (PFMS) using the SynchroMed™ II infusion system as an alternative to systemic opioids for the treatment of chronic, intractable, non-malignant primary back pain with or without leg pain.

Study identification

NCT ID
NCT03761277
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
MedtronicNeuro
Industry
Enrollment
93 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 16, 2019 (Actual)
Primary completion
Dec 6, 2021 (Actual)
Completion
Dec 6, 2021 (Actual)
Last update posted
Feb 8, 2023

2019 – 2021

United States locations

U.S. sites
16
U.S. states
12
U.S. cities
16
Facility City State ZIP Site status
Neuroversion Anchorage Alaska 99508 —
Coastal Pain and Spinal Diagnostics Carlsbad California 92009 —
Napa Valley Orthopaedic Medical Group Napa California 94558 —
Florida Pain Institute Merritt Island Florida 32935 —
Regional Brain & Spine, LLC Cape Girardeau Missouri 63701 —
Christian Hospital Pain Management St Louis Missouri 63136 —
Comprehensive and Interventional Pain Management Henderson Nevada 89052 —
The Pain Management Center Voorhees Township New Jersey 08043 —
Premier Pain Treatment Institute Mount Orab Ohio 45154 —
Clinical Investigations, LLC Edmond Oklahoma 73013 —
Moss Rehabilitation-Einstein Healthcare Network Elkins Park Pennsylvania 19027 —
University of Texas Medical Branch Galveston Texas 77555 —
Precision Spine Care Tyler Texas 75701 —
University of Virginia Pain Management Center Charlottesville Virginia 22908 —
Eastern Virginia Medical School Norfolk Virginia 23507 —
Northwest Pain Care, Inc. Spokane Washington 99201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03761277, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 8, 2023 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03761277 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →